Department of Health and Rehabilitation Sciences, University of Western Ontario, London, Ontario, Canada.
Department of Occupational Therapy, University of Florida, College of Public Health and Health Professions, Gainesville, Florida, the United States.
Arch Phys Med Rehabil. 2019 Aug;100(8):1534-1555. doi: 10.1016/j.apmr.2018.12.029. Epub 2019 Jan 26.
To critically appraise the evidence for the clinical determinants of fitness to drive in adults with multiple sclerosis (MS).
The research librarian and lead author searched 7 databases for driving simulator and on-road studies for adults with MS published in the English language from 1991 to 2018.
Three reviewers independently screened titles, abstracts, and full-texts for studies with: cohort, case-control, or cross-sectional designs; participants, 18 years or older, with relapsing or progressive MS; visual, cognitive, or motor clinical assessments as predictors; and driving performance through simulator or fitness to drive through on-road assessment as outcomes.
Using the 2017 American Academy of Neurology guidelines, reviewers independently classified each study from class I to class IV, or highest to lowest amount of rigor. For each clinical assessment, reviewers independently rated the level of confidence for predicting driving performance or fitness to drive from level A, highly probable; B, probable; C, possible; to level U, insufficient conclusions.
Through qualitative synthesis, 2 class III and 4 class IV driving simulator studies employed 24 clinical assessments with level C (n=4) or level U (n=20) confidence for predicting driving performance. Six class II and 3 class IV on-road studies employed 35 clinical assessments with level B (n=9), level C (n=22), or level U (n=4) confidence for predicting fitness to drive.
This systematic review identified mostly insufficient conclusions for predicting driving performance in driving simulator studies, and possible conclusions for predicting fitness to drive in on-road studies. The best available evidence suggests that the Stroke Driver Screening Assessment and Useful Field of View test probably predict fitness to drive in adults with MS (level B). Class I studies that compare predictors of fitness to drive with large prospective samples of adults with and without MS are necessary for highly probable conclusions.
批判性评价成年人多发性硬化症(MS)驾驶适应性的临床决定因素的证据。
研究图书管理员和主要作者在 1991 年至 2018 年间以英文发表的驾驶模拟器和道路上的成年人多发性硬化症研究为基础,在 7 个数据库中进行了搜索。
三名审查员独立筛选标题、摘要和全文,以选择具有以下特点的研究:队列、病例对照或横断面设计;参与者年龄在 18 岁或以上,患有复发性或进行性多发性硬化症;视觉、认知或运动临床评估作为预测因素;以及通过模拟器或道路评估的驾驶性能作为结果。
使用 2017 年美国神经病学学会指南,审查员独立地将每项研究从 I 级到 IV 级进行分类,或从最严格到最不严格的级别进行分类。对于每项临床评估,审查员独立地评估了预测驾驶性能或驾驶适应性的可能性水平,从 A 级(高度可能)到 U 级(无结论)。
通过定性综合,2 项 III 级和 4 项 IV 级驾驶模拟器研究采用了 24 项临床评估,其预测驾驶性能的可信度为 C 级(n=4)或 U 级(n=20)。6 项 II 级和 3 项 IV 级道路研究采用了 35 项临床评估,其预测驾驶适应性的可信度为 B 级(n=9)、C 级(n=22)或 U 级(n=4)。
这项系统评价确定了驾驶模拟器研究中预测驾驶性能的结论大多不充分,而道路研究中预测驾驶适应性的结论则可能。最好的现有证据表明,中风驾驶员筛查评估和有用视野测试可能预测成年人多发性硬化症的驾驶适应性(B 级)。需要进行 I 级研究,将驾驶适应性的预测因素与患有和不患有多发性硬化症的成年人的大型前瞻性样本进行比较,才能得出高度可能的结论。